X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-15 | CRNX | Pizzuti Dana | Chief Med, Dev Officer | S - Sale+OE | $44.47 | -14,375 | 27,786 | -34% | -$639,256 | |||||
| D | 2024-04-04 | CRNX | Struthers Richard Scott | Pres, CEO | S - Sale+OE | $49.17 | -40,951 | 1,139,640 | -3% | -$2,013,561 | |||||
| D | 2024-03-28 | CRNX | Okey Stephanie | Dir | S - Sale+OE | $46.38 | -17,500 | 6,000 | -74% | -$811,650 | |||||
| D | 2024-03-22 | CRNX | Knight Jeff E. | COO | S - Sale+OE | $44.31 | -32,359 | 52,580 | -38% | -$1,433,675 | |||||
| D | 2024-03-20 | CRNX | Pizzuti Dana | Chief Med, Dev Officer | S - Sale+OE | $44.06 | -15,089 | 27,786 | -35% | -$664,763 | |||||
| D | 2024-03-20 | CRNX | Fust Matthew K | Dir | S - Sale+OE | $44.14 | -60,000 | 18,536 | -76% | -$2,648,150 | |||||
2024-03-19 | CRNX | Wilson Marc | CFO | S - Sale | $42.91 | -6,942 | 110,630 | -6% | -$297,881 | ||||||
2024-01-25 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $37.26 | -3,000 | 73,298 | -4% | -$111,780 | ||||||
2024-01-10 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $37.65 | -3,000 | 76,298 | -4% | -$112,950 | ||||||
| D | 2024-01-03 | CRNX | Pizzuti Dana | Chief Med, Dev Officer | S - Sale+OE | $35.00 | -14,375 | 5,911 | -71% | -$503,125 | |||||
| D | 2024-01-02 | CRNX | Wilson Marc | CFO | S - Sale+OE | $35.47 | -10,000 | 96,055 | -9% | -$354,700 | |||||
2023-12-26 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $35.89 | -3,000 | 79,298 | -4% | -$107,670 | ||||||
| D | 2023-12-21 | CRNX | Pizzuti Dana | Chief Med, Dev Officer | S - Sale+OE | $34.57 | -9,583 | 5,911 | -62% | -$331,284 | |||||
2023-12-11 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $32.87 | -3,000 | 82,298 | -4% | -$98,610 | ||||||
2023-11-27 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $31.84 | -3,000 | 85,298 | -3% | -$95,520 | ||||||
| DM | 2023-11-02 | CRNX | Struthers Richard Scott | Pres, CEO | S - Sale+OE | $30.56 | -200,000 | 1,037,327 | -16% | -$6,111,440 | |||||
| D | 2023-11-01 | CRNX | Wilson Marc | CFO | S - Sale+OE | $28.75 | -10,000 | 95,601 | -9% | -$287,500 | |||||
| D | 2023-10-17 | CRNX | Krasner Alan Seth | Chief Medical Officer | S - Sale+OE | $30.00 | -7,000 | 43,210 | -14% | -$210,000 | |||||
| M | 2023-07-11 | CRNX | Struthers Richard Scott | Pres, CEO | S - Sale | $20.21 | -50,000 | 1,027,327 | -5% | -$1,010,317 | |||||
| D | 2023-06-20 | CRNX | Wilson Marc | CFO | S - Sale+OE | $19.97 | -30,922 | 95,158 | -25% | -$617,403 | |||||
2023-06-16 | CRNX | Struthers Richard Scott | Pres, CEO | S - Sale | $20.81 | -50,000 | 1,077,327 | -4% | -$1,040,500 | ||||||
2023-06-08 | CRNX | Vivaldi Coelho Rogerio | Dir | P - Purchase | $22.06 | +5,000 | 5,000 | New | +$110,300 | ||||||
2023-04-05 | CRNX | Pizzuti Dana | Chief Development Officer | S - Sale | $16.15 | -8,212 | 4,500 | -65% | -$132,624 | ||||||
2023-02-01 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $19.59 | -3,126 | 64,689 | -5% | -$61,238 | ||||||
2023-01-25 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $21.07 | -8,336 | 67,815 | -11% | -$175,640 | ||||||
2023-01-17 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $18.00 | -3,126 | 76,151 | -4% | -$56,268 | ||||||
2023-01-03 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $18.35 | -3,126 | 79,277 | -4% | -$57,362 | ||||||
2022-12-15 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $16.00 | -3,126 | 82,403 | -4% | -$50,016 | ||||||
2022-12-01 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $17.84 | -3,126 | 84,968 | -4% | -$55,768 | ||||||
2022-11-15 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $18.72 | -3,126 | 88,094 | -3% | -$58,519 | ||||||
2022-11-01 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $18.52 | -3,126 | 91,220 | -3% | -$57,894 | ||||||
2022-10-17 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $17.73 | -3,126 | 94,346 | -3% | -$55,424 | ||||||
2022-10-03 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $19.64 | -3,126 | 97,472 | -3% | -$61,395 | ||||||
2022-09-15 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $21.01 | -4,168 | 100,598 | -4% | -$87,570 | ||||||
2022-09-07 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $21.00 | -1,042 | 104,766 | -1% | -$21,884 | ||||||
2022-09-01 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $18.59 | -3,126 | 105,808 | -3% | -$58,112 | ||||||
2022-07-26 | CRNX | Knight Jeff E. | COO | S - Sale | $20.70 | -1,152 | 4,950 | -19% | -$23,847 | ||||||
| D | 2022-07-13 | CRNX | Fust Matthew K | Dir | S - Sale+OE | $20.96 | -5,700 | 12,536 | -31% | -$119,455 | |||||
2022-05-02 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $20.10 | -3,247 | 107,598 | -3% | -$65,252 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |